(Q49553520)

21 February 2018

http://europepmc.org/abstract/MED/29385376

title

Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia. (English)

1 reference

21 February 2018

http://europepmc.org/abstract/MED/29385376

1 reference

Jae H Park

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6637939&resulttype=core&format=json

15 May 2020

Isabelle Rivière

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6637939&resulttype=core&format=json

15 May 2020

Mithat Gonen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6637939&resulttype=core&format=json

15 May 2020

Xiuyan Wang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6637939&resulttype=core&format=json

15 May 2020

Brigitte Sénéchal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6637939&resulttype=core&format=json

15 May 2020

Kevin J Curran

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6637939&resulttype=core&format=json

15 May 2020

Craig Sauter

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6637939&resulttype=core&format=json

15 May 2020

Yongzeng Wang

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6637939&resulttype=core&format=json

15 May 2020

Bianca Santomasso

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6637939&resulttype=core&format=json

15 May 2020

Elena Mead

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6637939&resulttype=core&format=json

15 May 2020

Mikhail Roshal

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6637939&resulttype=core&format=json

15 May 2020

Peter Maslak

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6637939&resulttype=core&format=json

15 May 2020

Marco Davila

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6637939&resulttype=core&format=json

15 May 2020

Renier J Brentjens

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6637939&resulttype=core&format=json

15 May 2020

Michel Sadelain

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6637939&resulttype=core&format=json

15 May 2020

language of work or name

English

0 references

publication date

1 February 2018

1 reference

21 February 2018

http://europepmc.org/abstract/MED/29385376

published in

The New England Journal of Medicine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6637939&resulttype=core&format=json

15 May 2020

volume

378

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6637939&resulttype=core&format=json

15 May 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6637939&resulttype=core&format=json

15 May 2020

page(s)

449-459

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6637939&resulttype=core&format=json

Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15.

15 May 2020

cites work

1 reference

12 December 2020

Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study

1 reference

12 December 2020

Outcome of treatment after first relapse in adults with acute lymphoblastic leukemia initially treated by the LALA-94 trial

1 reference

12 December 2020

Outcome of adults with acute lymphocytic leukemia after second salvage therapy

1 reference

12 December 2020

Manufacturing validation of biologically functional T cells targeted to CD19 antigen for autologous adoptive cell therapy

1 reference

12 December 2020

Defining the course and prognosis of adults with acute lymphocytic leukemia in first salvage after induction failure or short first remission duration

1 reference

12 December 2020

Targeted therapy with the T-cell-engaging antibody blinatumomab of chemotherapy-refractory minimal residual disease in B-lineage acute lymphoblastic leukemia patients results in high response rate and prolonged leukemia-free survival.

1 reference

12 December 2020

Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias

1 reference

12 December 2020

Outcome of relapsed adult lymphoblastic leukemia depends on response to salvage chemotherapy, prognostic factors, and performance of stem cell transplantation.

1 reference

12 December 2020

CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia

1 reference

12 December 2020

Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia

1 reference

12 December 2020

Chimeric antigen receptor T cells for sustained remissions in leukemia

1 reference

12 December 2020

T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial

1 reference

12 December 2020

Minimal residual disease diagnostics in acute lymphoblastic leukemia: need for sensitive, fast, and standardized technologies

1 reference

12 December 2020

The pharmacology of second-generation chimeric antigen receptors.

1 reference

12 December 2020

Structural Design of Engineered Costimulation Determines Tumor Rejection Kinetics and Persistence of CAR T Cells

1 reference

12 December 2020

Acquisition of a CD19-negative myeloid phenotype allows immune escape of MLL-rearranged B-ALL from CD19 CAR-T-cell therapy

1 reference

12 December 2020

CD19 CAR-T cells of defined CD4+:CD8+ composition in adult B cell ALL patients

1 reference

12 December 2020

CD19-targeted CAR T-cell therapeutics for hematologic malignancies: interpreting clinical outcomes to date

1 reference

12 December 2020

Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia

1 reference

12 December 2020

Standardized flow cytometry for highly sensitive MRD measurements in B-cell acute lymphoblastic leukemia

1 reference

12 December 2020

Long-term relapse-free survival in a phase 2 study of blinatumomab for the treatment of patients with minimal residual disease in B-lineage acute lymphoblastic leukemia

1 reference

12 December 2020

Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia

1 reference

12 December 2020

T-cell invigoration to tumour burden ratio associated with anti-PD-1 response.

1 reference

12 December 2020

Identifiers

DOI

10.1056/NEJMOA1709919

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6637939&resulttype=core&format=json

15 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6637939&resulttype=core&format=json

15 May 2020

1 reference